Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings.
暂无分享,去创建一个
A 65-year-old man underwent elective percutaneous coronary intervention for a stenosis in the proximal left anterior descending artery (LAD). As part of the PROGRESS study (designed as a first-in-man coronary study in 65 patients in seven European centres), a 3.5 × 15 mm magnesium-based bioabsorbable stent (Lekton Magic Stent, Biotronik, Bulach, Switzerland) was implanted achieving an excellent angiographic result. Fifteen months following the initial intervention, an exercise treadmill test to evaluate exertional dyspnoea was positive. Angiography revealed a new and separate lesion in the …
[1] E. Antman,et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. , 2005, JAMA.
[2] B. Brodie,et al. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. , 2003, American heart journal.